{"id":"https://openalex.org/W2115687136","doi":"https://doi.org/10.1016/s0376-8716(03)00055-3","title":"From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States","display_name":"From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States","alternate_titles":[],"publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W2115687136","doi":"https://doi.org/10.1016/s0376-8716(03)00055-3","mag":"2115687136","pmid":"https://pubmed.ncbi.nlm.nih.gov/12738346"},"language":"en","primary_location":{"id":"doi:10.1016/s0376-8716(03)00055-3","doi":"https://doi.org/10.1016/s0376-8716(03)00055-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0376-8716(03)00055-3","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2115687136"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047282391","display_name":"Jerome H. Jaffe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J JAFFE","raw_affiliation_strings":["Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, 701 West Pratt Street, Baltimore, MD 21201, USA. jhjaffe@aol.com","Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, 701 West Pratt Street, Baltimore, MA 21201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, 701 West Pratt Street, Baltimore, MD 21201, USA. jhjaffe@aol.com","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, 701 West Pratt Street, Baltimore, MA 21201, USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091770296","display_name":"Charles O\u2019Keeffe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125531","display_name":"Reckitt Benckiser (United States)","ror":"https://ror.org/030893n97","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115825","https://openalex.org/I4210125531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles O'Keeffe","raw_affiliation_strings":["Reckitt Benckiser Pharmaceuticals Inc., 10710 Midlothian Turnpike, Richmond, VA 23235, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reckitt Benckiser Pharmaceuticals Inc., 10710 Midlothian Turnpike, Richmond, VA 23235, USA","institution_ids":["https://openalex.org/I4210125531"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5047282391"],"corresponding_institution_ids":["https://openalex.org/I126744593"],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":null,"fwci":8.8159,"has_fulltext":false,"cited_by_count":180,"citation_normalized_percentile":{"value":0.97786536,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"70","issue":"2","first_page":"S3","last_page":"S11"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/opioid-addiction-treatment","display_name":"opioid dependence treatment","score":0.6290000081062317},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.8920000195503235},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.9679999947547913},{"id":"https://openalex.org/keywords/fda-drug-regulation","display_name":"FDA drug regulation","score":0.6610000133514404},{"id":"https://openalex.org/keywords/history-of-drug-policy","display_name":"drug policy history","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.7724539041519165},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.6931115984916687},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5852319598197937},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.5273911356925964},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.4622068405151367},{"id":"https://openalex.org/C2777351106","wikidata":"https://www.wikidata.org/wiki/Q49371","display_name":"Legislation","level":2,"score":0.4593939781188965},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4465218186378479},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.27014875411987305},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2402760088443756},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22693803906440735},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.1584090292453766},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.14990133047103882},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D016320","descriptor_name":"Substance Abuse Treatment Centers","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D016320","descriptor_name":"Substance Abuse Treatment Centers","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0376-8716(03)00055-3","doi":"https://doi.org/10.1016/s0376-8716(03)00055-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0376-8716(03)00055-3","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},{"id":"pmid:12738346","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12738346","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and alcohol dependence","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875},{"id":"https://metadata.un.org/sdg/16","display_name":"Peace, justice, and strong institutions","score":0.8046000003814697}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320314111","display_name":"Reckitt Benckiser Pharmaceuticals","ror":"https://ror.org/01g87hr29"},{"id":"https://openalex.org/F4320315405","display_name":"American Academy of Addiction Psychiatry","ror":"https://ror.org/02428c123"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337426","display_name":"Center for Substance Abuse Treatment","ror":"https://ror.org/03t3qg659"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W601133387","https://openalex.org/W1979184030","https://openalex.org/W1980042337","https://openalex.org/W1980315117","https://openalex.org/W1984345629","https://openalex.org/W1992389336","https://openalex.org/W2009220908","https://openalex.org/W2010906830","https://openalex.org/W2047657131","https://openalex.org/W2062971972","https://openalex.org/W2063539450","https://openalex.org/W2089650958","https://openalex.org/W2097145370","https://openalex.org/W2227645964","https://openalex.org/W2401144027","https://openalex.org/W3022206625","https://openalex.org/W4236731515"],"related_works":["https://openalex.org/W2162361345","https://openalex.org/W17608643","https://openalex.org/W2108082202","https://openalex.org/W2270480675","https://openalex.org/W1983452093","https://openalex.org/W7097959034","https://openalex.org/W2044420094","https://openalex.org/W2113152002","https://openalex.org/W3193120097","https://openalex.org/W4315474237"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2115687136","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
